Search

everythinglearnresearchcommunity

for

Search:↓

Cryotherapy with precise temperature control is a promising treatment for alopecia areata.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

Baricitinib improves alopecia areata and may help psoriasis but might not be ideal for psoriatic arthritis.

MK-5108 is safe and shows potential against tumors, especially alone.

Cognitive-behavioral therapy with habit reversal training is the most effective treatment for trichotillomania.

Baricitinib treatment can help regrow scalp hair and eyebrows or eyelashes in people with severe alopecia areata.

Baricitinib maintains significant hair regrowth in severe alopecia areata over three years.

Phytotherapy offers a safer alternative for managing hair loss with fewer side effects.

Ritlecitinib effectively treats alopecia areata in patients 12 and older with fewer side effects.

Ritlecitinib helps reduce inflammation and promote hair regrowth in alopecia areata, especially in patchy-type cases.

An 8-year-old with severe hair loss regrew all hair after six months of tofacitinib treatment.

New male contraceptive pills show promise in reducing sperm production with mild side effects.

New treatments for hair loss may target specific pathways and generate new hair follicles.

A new method can quickly and accurately detect drugs in hair.

The new delivery system improved raloxifene's skin absorption and effectiveness against cancer cells.

A new mix of anthralin and calcipotriene might help treat severe hair loss.

We need safe, affordable drugs to fight coronaviruses effectively.

GLP-1 receptor agonists may increase the risk of a specific type of hair loss called androgenetic alopecia.

Extracts improve hair growth in alopecia.

Baricitinib treatment helps regrow eyebrow, eyelash, and scalp hair in severe alopecia areata, improving patients' emotional well-being and quality of life.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

Irish dermatologists use JAK inhibitors for alopecia areata but want standardized treatment guidelines.

The paper concludes that the new medication baricitinib needs further testing in a more diverse group of patients with alopecia areata.

Baricitinib helps regrow hair in severe alopecia areata but has side effects like infections and headaches.

The research found how GPCR Class A Rhodopsin receptors are related and suggested possible substances they interact with.

JAK inhibitors help hair growth by boosting beta-catenin activity in hair root cells.

Further trials are needed to explore the efficacy of triamcinolone acetonide in dermatology.